论文部分内容阅读
目的:观察多潘立酮联合复方消化酶胶囊治疗功能性消化不良的临床疗效。方法:选取2008年1月—2013年1月我院收治的功能性消化不良患者38例,随机分为两组,对照组(19例)单用多潘立酮治疗,观察组(19例)采用多潘立酮联合复方消化酶治疗,比较两组患者的临床疗效及不良反应。结果:观察组治疗总有效率为89.47%,对照组为63.16%,两组比较差异有显著性(P<0.05)。观察组的不良反应发生率为5.26%,对照组为10.52%,两组比较无显著性差异(P>0.05)。结论:多潘立酮联合复方消化酶治疗功能性消化不良临床效果可靠、不良反应少,值得临床推广使用。
Objective: To observe the clinical efficacy of domperidone combined with compound digestive enzyme capsule in the treatment of functional dyspepsia. Methods: Thirty-eight patients with functional dyspepsia treated in our hospital from January 2008 to January 2013 were randomly divided into two groups. The control group (19 cases) was treated with domperidone alone. The observation group (19 cases) was treated with domperidone Compound digestive enzyme therapy, the clinical efficacy and adverse reactions of two groups were compared. Results: The total effective rate of the observation group was 89.47%, while that of the control group was 63.16%. There was significant difference between the two groups (P <0.05). The incidence of adverse reactions in the observation group was 5.26% and that in the control group was 10.52%. There was no significant difference between the two groups (P> 0.05). Conclusion: Domperidone combined with compound digestive enzyme in the treatment of functional dyspepsia has reliable clinical effect and few adverse reactions, which is worthy of clinical promotion.